派林生物: management transactions · France · AMF SZSE:000403 FR FR · AMF Mcap 13.0Bn€
Browse the full directors' dealings record of 派林生物, a listed issuer based in France. Shares are listed on FR FR, under the supervision of AMF. Market capitalisation: €13bn. The latest transaction was filed on 20 May 2026 (Purchase). Among the most active insiders: 黄灵谋. The full history is openly available.
Financial data FY ended December 2025 · cache
Income statement
Revenue 2.63 Bn€
Gross profit 1.09 Bn€ 42% margin
Net income 419.3 M€ 15.9% margin
Balance sheet & cash
Market cap 13.01 Bn€
Total debt 813.1 M€
Free Cash Flow −549.4 M€
Last declaration on 20 May 2026
Declarations 23 total
Executives ● Purchase7 SZSE
6,000 shares
SZSE:273000000639571100 · 20 May 2026
Ideal exit: 14 Feb 2027 (T+270) Executives ● Purchase7 SZSE
4,000 shares
SZSE:273000000635414240 · 19 May 2026
Ideal exit: 13 Feb 2027 (T+270) Executives ● Purchase22 SZSE
€13,056 5,000 shares
SZSE:173000008868500400 · 25 Apr 2025
Ideal exit: 20 Jan 2026 (T+270) Executives ● Purchase18 SZSE
€19,584 7,500 shares
SZSE:173000008868500580 · 25 Apr 2025
Ideal exit: 20 Jan 2026 (T+270) Executives ● Purchase7 SZSE
€542 200 shares
SZSE:173000008717793300 · 24 Feb 2025
Ideal exit: 21 Nov 2025 (T+270) Executives ● Purchase7 SZSE
€5,572 2,000 shares
SZSE:173000008552387420 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) Executives ● Purchase18 SZSE
€4,321 1,500 shares
SZSE:173000008451201340 · 14 Jan 2025
Ideal exit: 11 Oct 2025 (T+270) Executives ● Purchase18 SZSE
€2,185 800 shares
SZSE:173000008409120800 · 7 Jan 2025
Ideal exit: 4 Oct 2025 (T+270) Executives ● Purchase7 SZSE
€5,506 2,000 shares
SZSE:173000008405393300 · 6 Jan 2025
Ideal exit: 3 Oct 2025 (T+270) Executives ● Purchase11 SZSE
€27,529 10,000 shares
SZSE:173000008405393340 · 6 Jan 2025
Ideal exit: 3 Oct 2025 (T+270) Executives ● Purchase18 SZSE
€5,631 2,000 shares
SZSE:173000008396452580 · 2 Jan 2025
Ideal exit: 29 Sept 2025 (T+270) Executives ● Purchase11 SZSE
€14,076 5,000 shares
SZSE:173000008396452540 · 2 Jan 2025
Ideal exit: 29 Sept 2025 (T+270) Executives ● Sale7 SZSE
3,500,000 shares
SZSE:173000006682573300 · 26 Jun 2023
Executives ● Sale7 SZSE
32,600 shares
SZSE:173000006618752160 · 25 May 2023
Executives ● Sale7 SZSE
41,000 shares
SZSE:173000006397250720 · 24 Mar 2023
Executives ● Sale7 SZSE
59,000 shares
SZSE:173000006385524860 · 23 Mar 2023
Executives ● Sale7 SZSE
32,000 shares
SZSE:173000006379791870 · 22 Mar 2023
Executives ● Sale7 SZSE
2,000,000 shares
SZSE:173000006130764540 · 13 Dec 2022
Executives ● Purchase7 SZSE
11,000 shares
SZSE:173000004832742720 · 14 Sept 2021
Ideal exit: 11 Jun 2022 (T+270) Executives ● Purchase7 SZSE
100,000 shares
SZSE:173000005677879260 · 14 Sept 2021
Ideal exit: 11 Jun 2022 (T+270) Executives ● Purchase22 SZSE
2,800 shares
SZSE:173000005355032420 · 14 Sept 2021
Ideal exit: 11 Jun 2022 (T+270) Executives ● Purchase7 SZSE
4,000 shares
SZSE:173000004826249340 · 10 Sept 2021
Ideal exit: 7 Jun 2022 (T+270) Executives ● Purchase11 SZSE
2,800 shares
SZSE:173000004818779260 · 10 Sept 2021
Ideal exit: 7 Jun 2022 (T+270)
